Neufeld, Austria – In line with its commitment to transform medical imaging with cell-specific and gadolinium-free MRI contrast agents, Sanochemia Pharmazeutika is pleased to announce the appointment of Faizal Mansor as Head of Product Strategy.
Faizal brings over two decades of leadership experience in the medical imaging and pharmaceutical industry, most recently serving as Global Head of Marketing at Guerbet. His deep expertise spans Asia-Pacific commercial strategy, global marketing, and successful product launches.
With a proven track record of driving innovation, building global partnerships, and leading product strategies, Faizal will play a central role in shaping Sanochemia’s long-term roadmap and accelerating global market access of its new contrast portfolio.
“I’m excited to join Sanochemia and help shape the future of medical imaging,” says Faizal Mansor. “By leveraging the pioneering portfolio, we aim to bring precision imaging to the cellular level — transforming diagnostics for clinicians and patients around the world.”
In his new role, Faizal will lead the company’s global product strategy, with a focus on market expansion and commercialization of Sanochemia’s cell-specific contrast agents — in addition to evolving the integrated branded generic contrast media portfolio.